Cargando…
Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway
Gonadotropins, including luteinizing hormone (LH) and follicle stimulating hormone (FSH), are conducive to the growth of ovarian cancer based on the ‘gonadotropin theory’ and are regulated by gonadotropin-releasing hormone (GnRH). The present study was carried out to investigate the effect of gosere...
Autores principales: | Zhang, Ning, Qiu, Junjun, Zheng, Tingting, Zhang, Xiaodan, Hua, Keqin, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802025/ https://www.ncbi.nlm.nih.gov/pubmed/29286125 http://dx.doi.org/10.3892/or.2017.6159 |
Ejemplares similares
-
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005) -
The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
por: Gao, Min, et al.
Publicado: (2012) -
A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
por: Lind, M. J., et al.
Publicado: (1992) -
Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR
por: Du, Feng, et al.
Publicado: (2019) -
The Akt Forkhead Box O Transcription Factor Axis Regulates Human Cytomegalovirus Replication
por: Zhang, Hongbo, et al.
Publicado: (2022)